• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Bicycle Health, Albertsons Partner to Boost Access to Opioid use Disorder Injections

Share:

September 11, 2023

Bicycle Health, a virtual opioid use disorder treatment provider, has partnered with Albertsons, a supermarket chain, to offer monthly buprenorphine injections for opioid use disorder through its pharmacies in 17 states. Patients can receive prescriptions for the extended-release injections (Sublocade) via Bicycle Health’s app and have them administered by on-site pharmacists at participating Albertsons locations. This collaboration aims to expand access to opioid use disorder medications and contribute to addressing the ongoing opioid crisis.

Virtual opioid use disorder treatment company Bicycle Health is partnering with supermarket chain Albertsons to allow the telehealth company’s providers to prescribe buprenorphine monthly injections for opioid use disorder that can be filled inside Albertsons pharmacies across 17 states.

Buprenorphine has been shown to reduce the risk of death after an opioid overdose.

Bicycle Health’s doctors, physician assistants and nurse practitioners will be able to prescribe the extended-release injections (known as Sublocade) as an alternative to buprenorphine/naloxone (Suboxone), which is an oral medication taken daily.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Patients can be prescribed the medication virtually through the company’s app and receive the injection from an on-site pharmacist at one of the 700 participating Albertsons’ pharmacies.

“Increasing access to medications for opioid use disorder (MOUD) is essential to overcoming the nation’s opioid crisis. By expanding the availability of Sublocade to Albertsons Cos. pharmacies will help protect the progress made during COVID and accelerate utilization of MOUD by making new treatment options available,” Ankit Gupta, founder and CEO of Bicycle Health, said in a statement.

THE LARGER TREND

Bicycle Health has announced several partnerships over the past year.

In February, Bicycle Health teamed with medical and mental healthcare provider Wellpath to provide virtual opioid use disorder services to individuals living in the Federal Bureau of Prisons’ Residential Reentry Centers.

Last year, the company partnered with emergency telehealth provider Tele911 to connect patients who experienced an overdose or have symptoms of opioid use disorder to Bicycle Health providers after being evaluated by a Tele911 emergency physician.

Source: MobihealthNews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Olive Hits $1.5B Valuation with Additional $225.5M Funding for AI-Powered Digital Employee PlatformOlive Hits $1.5B Valuation with Additional $225.5M Funding for AI-Powered Digital Employee Platform
  • Enliven Therapeutics and Imara Announce Merger AgreementEnliven Therapeutics and Imara Announce Merger Agreement
  • California Physician Practices to Use Apple Watches to Advance Physician-Patient CommunicationCalifornia Physician Practices to Use Apple Watches to Advance Physician-Patient Communication
  • Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of DedicaidTelix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid
  • Health Benefits, Insurance Navigation Chatbot Sensely Lands $15MHealth Benefits, Insurance Navigation Chatbot Sensely Lands $15M
  • Livongo will work with Apple Watch and other wearables to nudge you into healthy habitsLivongo will work with Apple Watch and other wearables to nudge you into healthy habits
  • Bipolar Disorder Therapeutics Global Market Report 2022: Featuring Key Players AbbVie, Pfizer, GlaxoSmithKline & OthersBipolar Disorder Therapeutics Global Market Report 2022: Featuring Key Players AbbVie, Pfizer, GlaxoSmithKline & Others
  • Serina Therapeutics and AgeX Therapeutics Enter into Merger AgreementSerina Therapeutics and AgeX Therapeutics Enter into Merger Agreement

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications